Sign Up to like & get
recommendations!
0
Published in 2022 at "Korean Journal of Ophthalmology : KJO"
DOI: 10.3341/kjo.2022.0061
Abstract: Purpose Netarsudil is a Rho kinase inhibitor and the first new class of clinically useful ocular hypotensive agents. In this study, we conducted a systematic literature review and meta-analysis to summarize and synthesize the available…
read more here.
Keywords:
netarsudil latanoprost;
latanoprost monotherapy;
therapy;
fdc therapy ... See more keywords